Cargando…

Tofacitinib Adherence and Outcomes in Refractory Inflammatory Bowel Disease

BACKGROUND: Tofacitinib has been approved for moderate-to-severe ulcerative colitis and studied in Crohn’s disease. Understanding medication adherence to oral medications in severe disease is essential. METHODS: We retrospectively reviewed adherence and real-world outcomes of inflammatory bowel dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiles, C Alex, Shah, Nisha B, Bell, Jake, Pabla, Baldeep S, Scoville, Elizabeth A, Dalal, Robin L, Beaulieu, Dawn B, Schwartz, David A, Horst, Sara N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Observations and Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802481/ https://www.ncbi.nlm.nih.gov/pubmed/36777280 http://dx.doi.org/10.1093/crocol/otab075

Ejemplares similares

Functional Medicine Approach to Patient Care Improves Sleep, Fatigue, and Quality of Life in Patients With Inflammatory Bowel Disease
por: Strobel, Thomas M, et al.
Publicado: (2022)

A Single Center Experience With Long-Term Ustekinumab Use and Reinduction in Patients With Refractory Crohn Disease
por: Bennett, Audrey, et al.
Publicado: (2020)

Gastroenterologist-Lead Management of Iron Deficiency Anemia in Inflammatory Bowel Disease Is Effective, Safe, and May Increase Quality of Life
por: Coe, Christopher L, et al.
Publicado: (2020)

Favorable Outcomes Combining Vedolizumab With Other Biologics or Tofacitinib for Treatment of Inflammatory Bowel Disease
por: Llano, Ernesto M, et al.
Publicado: (2021)

Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study
por: Basil, Miles, et al.
Publicado: (2021)

TELEmedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Does Not Improve Depressive Symptoms or General Quality of Life Compared With Standard Care at Tertiary Referral Centers
por: Schliep, Matthew, et al.
Publicado: (2020)

Adherence to Inflammatory Bowel Disease Medications in Southern New Zealand
por: Aluzaite, Kristina, et al.
Publicado: (2021)

Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study
por: Perin, Ramir Luan, et al.
Publicado: (2022)

Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018)

Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel Disease
por: Khakoo, Nidah S, et al.
Publicado: (2021)

Assessing Severity of Disease in Patients with Ulcerative Colitis
por: Pabla, Baldeep Singh, et al.
Publicado: (2020)

Tofacitinib in patients with refractory Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2020)

Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib
por: Kappelman, Michael D, et al.
Publicado: (2023)

Current practice and clinicians’ perception of medication non-adherence in patients with inflammatory bowel disease: A survey of 98 clinicians
por: Soobraty, Anisah, et al.
Publicado: (2017)

Atopic dermatitis: Tofacitinib, an option for refractory disease
por: Berbert Ferreira, Sineida, et al.
Publicado: (2020)

Tofacitinib for refractory ocular mucous membrane pemphigoid
por: James, Hayley, et al.
Publicado: (2021)

Tofacitinib in Refractory Scleritis: A Case Series
por: Dey, Suvankar, et al.
Publicado: (2023)

Polyarteritis nodosa: a case report of isolated large bowel involvement and surgical intervention
por: Sellyn, Georgina E, et al.
Publicado: (2023)

Nurse-Provided Medication Guidance for Improving Drug Adherence to Thiopurines in Outpatients With Inflammatory Bowel Disease: A Single-Center Prospective Study
por: Shinzaki, Shinichiro, et al.
Publicado: (2021)

Tofacitinib as an alternative therapy for refractory intestinal Behçet’s syndrome
por: Zou, Jun, et al.
Publicado: (2022)

Successful treatment of refractory IgA vasculitis with tofacitinib
por: Xu, Yi-Fei, et al.
Publicado: (2022)

Response to Oral Tofacitinib in Childhood Refractory Nipple Eczema
por: Asritha, C V V, et al.
Publicado: (2023)

Effects of electroacupuncture on bladder and bowel function in patients with transverse myelitis: a prospective observational study
por: Wu, Jiani, et al.
Publicado: (2018)

The Pseudomonas aeruginosa Exopolysaccharide Psl Facilitates Surface Adherence and NF-κB Activation in A549 Cells
por: Byrd, Matthew S., et al.
Publicado: (2010)

The Reliability of Patient Self-reported Utilization in an Inflammatory Bowel Diseases Learning Health System
por: van Deen, Welmoed K, et al.
Publicado: (2021)

Natural Transmission of Helicobacter saguini Causes Multigenerational Inflammatory Bowel Disease in C57/129 IL-10(−/−) Mice
por: Mannion, Anthony, et al.
Publicado: (2020)

Network-Based Prediction of Novel CRISPR-Associated Genes in Metagenomes
por: Weissman, Jake L., et al.
Publicado: (2020)

Exploring Reproductive Health Decision Experiences and Preferences of Women With Pediatric-Onset Inflammatory Bowel Diseases
por: Picciarelli, Zach, et al.
Publicado: (2021)

Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis
por: Vesely, Matthew D., et al.
Publicado: (2016)

Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib
por: Jia, Ertao, et al.
Publicado: (2020)

Nailfold Capillaroscopy as a Biomarker in the Evaluation of Pediatric Inflammatory Bowel Disease
por: Kurowski, Jacob A, et al.
Publicado: (2021)

Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical Complications
por: Berger, Matthew, et al.
Publicado: (2020)

Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission
por: Dubinsky, Marla C, et al.
Publicado: (2022)

Duodenal Ulceration following Holmium Laser Lithotripsy
por: Pabla, Baldeep, et al.
Publicado: (2019)

Simple Novel Screening Tool for Obstructive Sleep Apnea in Inflammatory Bowel Disease
por: Barnes, Alex, et al.
Publicado: (2023)

Case of Obstruction of the Bowels, with Remarks
Publicado: (1784)

Development of a sensitive biochemical assay for the detection of tofacitinib adherence
por: Church, Stephanie, et al.
Publicado: (2023)

Psychological perspective of medication adherence in transplantation
por: De Pasquale, Concetta, et al.
Publicado: (2016)

High Burden of Obesity and Low Rates of Weight Loss Pharmacotherapy in Inflammatory Bowel Disease: 10-Year Trend
por: Elangovan, Abbinaya, et al.
Publicado: (2023)

Fecal Incontinence in Inflammatory Bowel Disease
por: Kamal, Natasha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_58ci33mak3magqtoc79hnf3o2u